Home
All Journals
Expert Opinion on Therapeutic Targets
List of Issues
Volume 17, Issue 8

Expert Opinion on Therapeutic Targets

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Therapeutic Targets, Volume 17, Issue 8 (2013)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Targets, Volume 17, Issue 8 (2013)

See all volumes and issues

Vol 28, 2024 Vol 27, 2023 Vol 26, 2022 Vol 25, 2021 Vol 24, 2020 Vol 23, 2019 Vol 22, 2018 Vol 21, 2017 Vol 20, 2016 Vol 19, 2015 Vol 18, 2014 Volume 17, 2013 Vol 16, 2012 Vol 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

ADAMTS7: a promising new therapeutic target in coronary heart disease

Riyaz S Patel MD MRCP & Shu Ye MD PhD FRCPath

Pages: 863-867

Published online: 06 Jul 2013

AbstractforADAMTS7: a promising new therapeutic target in coronary heart disease | Full Text | References | PDF (333.7 KB)

1849 Views
15 CrossRef citations
0Altmetric

Free Access

Editorial

Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting

Christian Rolfo MD PhD, Antonio Russo, Daniele Santini, Giuseppe Bronte & Marc Peeters

Pages: 869-871

Published online: 15 Jul 2013

AbstractforDilemma in metastatic colorectal cancer: VEGF versus EGRF targeting | Full Text | References | PDF (224.1 KB)

947 Views
8 CrossRef citations
0Altmetric

Free Access

Editorial

Targeting RNA polymerase I transcription and the nucleolus for cancer therapy

Ross D Hannan, Denis Drygin & Richard B Pearson

Pages: 873-878

Published online: 17 Jul 2013

AbstractforTargeting RNA polymerase I transcription and the nucleolus for cancer therapy | Full Text | References | PDF (330.1 KB)

2125 Views
51 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Ephrins and pain

Ioanna Vasileiou, Ioannis Adamakis, Efstratios Patsouris & Stamatios Theocharis MD PhD

Pages: 879-887

Published online: 08 Jun 2013

AbstractforEphrins and pain | Full Text | References | PDF (395.8 KB)

335 Views
21 CrossRef citations
0Altmetric

Review Article

The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias

B Daan Westenbrink, Andrew G Edwards, Andrew D McCulloch & Joan Heller Brown PhD

Pages: 889-903

Published online: 24 Jun 2013

AbstractforThe promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias | Full Text | References | PDF (592.4 KB)

685 Views
24 CrossRef citations
0Altmetric

Review Article

The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity

Gudrun Ulrich-Merzenich & Heike Zeitler

Pages: 905-919

Published online: 06 Jun 2013

AbstractforThe lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity | Full Text | References | PDF (719.4 KB)

383 Views
11 CrossRef citations
0Altmetric

Review Article

Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia

Camilla Evangelisti PhD, Cecilia Evangelisti PhD, Daniela Bressanin PhD, Francesca Buontempo PhD, Francesca Chiarini PhD, Annalisa Lonetti PhD, Marina Soncin PhD, Antonino Spartà PhD, James A McCubrey MD PhD & Alberto M Martelli MD PhD

Pages: 921-936

Published online: 11 Jun 2013

AbstractforTargeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia | Full Text | References | PDF (584.9 KB)

288 Views
14 CrossRef citations
0Altmetric

Review Article

Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma

Fiona Murray PhD & Paul A Insel MD

Pages: 937-949

Published online: 07 May 2013

AbstractforTargeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma | Full Text | References | PDF (655.9 KB)

507 Views
21 CrossRef citations
0Altmetric

Review Article

Targeting membrane androgen receptors in tumors

Florian Lang, Konstantinos Alevizopoulos & Christos Stournaras

Pages: 951-963

Published online: 08 Jun 2013

AbstractforTargeting membrane androgen receptors in tumors | Full Text | References | PDF (657 KB)

328 Views
22 CrossRef citations
0Altmetric

Review Article

Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses

Vito Ferro PhD

Pages: 965-975

Published online: 24 Jun 2013

AbstractforHeparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses | Full Text | References | PDF (652 KB)

636 Views
27 CrossRef citations
0Altmetric

Review Article

Targeting liver X receptors in inflammation

Knut R Steffensen, Tomas Jakobsson & Jan-Åke Gustafsson

Pages: 977-990

Published online: 06 Jun 2013

AbstractforTargeting liver X receptors in inflammation | Full Text | References | PDF (784.5 KB)

794 Views
50 CrossRef citations
0Altmetric

Research Article

Article

Page: i

Published online: 17 Jul 2013

31 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Candidate molecular targets uncovered in mouse lifespan extension studies

Maria Vedunova et al.

Review Article | Published online: 30 Apr 2024

The role of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in cancer development and progression

Chandra K. Singh et al.

Review Article | Published online: 30 Apr 2024

Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress

Hui Chen et al.

Report | Published online: 29 Apr 2024

Arenobufagin induces cell apoptosis by modulating the cell cycle regulator claspin and the JNK pathway in nasopharyngeal carcinoma cells

Hsin-Yu Ho et al.

Article | Published online: 27 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Therapeutic Targets (Vol.17, Iss.8, 2013)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?